Cytosorbents Co. (NASDAQ:CTSO – Free Report) – Investment analysts at HC Wainwright boosted their FY2023 earnings per share (EPS) estimates for Cytosorbents in a report released on Wednesday, August 2nd. HC Wainwright analyst S. Lee now anticipates that the medical research company will post earnings per share of ($0.59) for the year, up from their […]
HC Wainwright reaffirmed their buy rating on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a research report report published on Wednesday morning, Benzinga reports. The brokerage currently has a $5.50 price objective on the medical research company’s stock. HC Wainwright also issued estimates for Cytosorbents’ FY2023 earnings at ($0.59) EPS, Q1 2024 earnings at […]
Cytosorbents Co (NASDAQ:CTSO) to Post FY2023 Earnings of ($0 59) Per Share, HC Wainwright Forecasts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Cytosorbents (NASDAQ:CTSO – Get Free Report) and Bioventus (NYSE:BVS – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations. Analyst Ratings This is a summary of current ratings […]
Cytosorbents Co. (NASDAQ:CTSO – Get Rating)’s stock price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $2.64 and traded as high as $3.24. Cytosorbents shares last traded at $3.11, with a volume of 24,015 shares traded. Analysts Set New Price […]